price close busi februari
new busi win set ramp review maintain
find well posit benefit converg popul
growth resourc volatil rapid industri across world compani
recur servic model drive high visibl even variabl macro environ
anoth quarter solid execut predict power platform record
new account win ep growth ex recal continu favor long-
term earn potenti favor long-term macro trend proven
execut lot room target market reiter buy rate
catalyst canaccord genuiti host ndr earli april presid
christoph beck boston
importantli pivot price volum show sign sustain
success record new win expect drive better growth come
quarter also significantli de-risk platform complet
difficult move new erp system us benefit follow fulli separ
upstream biz prepar forthcom spin oper stand-alon
suppli chain erp system european healthcar recal impact result
major cost behind compani plant produc sinc mid-decemb
coronaviru look serv modest headwind potenti addit
impact relat challeng persist imposs predict point
report sale y/i acquisit adjust sale constant
currenc ex championx steadi growth industri institut
segment offset softer result healthcar hamper
product recal adjust gross margin y/i driven
price lower deliv cost adjust fix currenc oper margin
y/i note adjust ep growth would
absent impact healthcar recal
guidanc get initi solid growth oper improv
expect off-set pension coronaviru
fx headwind specif adjust ep forecast
growth target year consolid adjust gross
margin expect sg percentag sale
tax rate adjust gross margin anticip
sg
given solid balanc sheet net debt adjust ebitda
healthi gener convers expect
expect remain key part strategi move forward perhap bolster
futur spin buy-back activ also expect pick-up post spin
report revenue/adjust ep vs consensu
guidanc estim adjust reflect
report result updat assumpt follow
introduc full detail
target equat price-to-earnings multipl adjust ep
estim acknowledg higher near-term multipl stay confid longer-
term earn power platform
canaccord genuiti global capit market group canaccord genuiti group inc cf tsx
recommend opinion express research report accur reflect research analyst person independ object
view compani secur subject report discuss herein
import inform pleas see import disclosur begin page document
report revenue/adjust ep vs street
guidanc report sale y/i
acquisit adjust sale constant currenc exclud championx
steadi growth industri institut segment offset softer
result healthcar hamper product recal adjust gross
margin y/i driven price lower deliv cost
adjust fix currenc oper margin y/i adjust
ep growth would absent impact healthcar recal
remind report result four segment global institut global
industri global energi
global industri om total sale y/i fix
currenc acquisit adjust acquisit adjust fix currenc
oper margin y/i increas y/i constant
currenc acquisit adjust corpor account win share gain help
total assur approach price overcom flattish industri trend ecolab
continu win busi key global custom increas penetr
share captur expect off-set challeng industri condit continu good
organ growth expect global y/i constant currenc
acquisit adjust good growth major busi continu
strong demand light industri strong growth mine modest growth
heavi industri manag expect continu good underli growth
off-set impact coronaviru china paper c/c
acquisit adjust reflect tough y/i comp slow containerboard
market expect flattish life scienc fix currenc
adjust acquisit good growth recent win solid price
led clean disinfect sale pharma person care market
particularli europ momentum expect continu platform move
forward textil roughli flat constant currenc organ
global institut om total sale y/i fix
currenc acquisit adjust fix currenc oper margin y/i
healthcar impact recal institut market
constant currenc acquisit adjust reflect plan exit lower
margin busi quarter impact moder global lodg growth
help off-set softer full-servic restaur foot traffic quarter latin america led
growth na apac modestli europ soft sale expect show solid
underli growth even purpos exit lower margin busi
serv diminish headwind global specialti kay y/i constant
currenc organ driven healthi on-going busi roll-out newer
account win despit modest industri trend growth expect remain strong
good growth global healthcar sale fix
currenc organ basi driven voluntari product recal sever infect
prevent product europ biofilm exclud issu sale y/i
hamper still ramp product post recal improv
result expect move year
global energi om total sale y/i c/c also
divestitur adjust championx sale reduc well
stimul activ product busi show good growth downstream
sale modestli driven intern activ fix currenc oper
margin acquisit adjust y/i manag expect
sale modestli growth product downstream activ
importantli separ cyclic upstream energi busi firmli
de-risk simultan tax-fre spin merger rate
look close end anti-trust clearanc alreadi grant continu
expect focus less cyclic platform sizabl runway growth
exist market clear potenti expans attract new area
gather increas interest particularli rapidli grow class sustainability-
centric investor newli form entiti own exist sharehold
make one-tim cash payment
om total sale y/i c/c also
organ adjust oper margin driven invest
global pest y/i c/c organ improv underli growth
driven new win expect partial off-set impact coronaviru
china colloid organ
guidanc guidanc get initi solid growth oper
improv expect off-set pension coronaviru
fx headwind specif adjust ep forecast
growth target year consolid
adjust gross margin expect sg percentag sale
tax rate adjust gross margin anticip
sg
balanc sheet total cash equival
net debt adjust ebitda net debt-to-tot capit
exclud debt item pension etc gener
oper year manag expect continu
healthi convers ni convers
competit regulatori dynam integr
compani report canaccord genuiti estim detail financi model includ balanc sheet incom statement cash flow project avail may
obtain contact canaccord genuiti sale person author analyst whose contact inform appear front page report
fiscal year year million except per share sale chang chang year sale gross gross margin gross adjust gross margin gener sale gain adjust ebitda margin oper margin oper adjust oper margin expens incom expens pre-tax pre-tax margin net incom non-controlling effect net incom net margin earn per share chang year net incom net margin earn per share chang year gross sheet account chip moor cfa current genuiti compani report canaccorcd genuiti estimatesoth stockhold inc nyse revenu earn model
